Spero Therapeutics
SPRO
#9007
Rank
โ‚ฌ0.11 B
Marketcap
1,98ย โ‚ฌ
Share price
-1.28%
Change (1 day)
80.49%
Change (1 year)

EPS for Spero Therapeutics (SPRO)

EPS in 2025 (TTM): -0,91ย โ‚ฌ

According to Spero Therapeutics's latest financial reports the company's current EPS (TTM) is -0,83ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -1,08ย โ‚ฌ.

EPS history for Spero Therapeutics from 2017 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,91ย โ‚ฌ-15.94%
2024-1,08ย โ‚ฌ
2022-1,41ย โ‚ฌ
2020-3,07ย โ‚ฌ9.39%
2019-2,81ย โ‚ฌ25.48%
2018-2,24ย โ‚ฌ-51.35%
2017-4,60ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Franklin Covey
FC
0,21ย โ‚ฌ-125.51%๐Ÿ‡บ๐Ÿ‡ธ USA
IBM
IBM
7,25ย โ‚ฌ-969.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
3,31ย โ‚ฌ-496.94%๐Ÿ‡จ๐Ÿ‡ฆ Canada